Global Patient Recruitment Services and Patient Retention Services Market Report to 2035: Players Featured Include BBK Worldwide, Continuum Clinical, IQVIA, United BioSource and WCG ThreeWire
Saturday, February 4, 2023
DUBLIN, Dec. 20, 2022 /PRNewswire/ -- The "Patient Recruitment Services and Patient Retention Services Market by Patient Recruitment Step, Trial Phase Therapeutic Area and Key Geographies, Industry Trends and Global Forecasts, 2022-2035" report has been added to ResearchAndMarkets.com's offering.
This report features an extensive study of the current market landscape and future potential of the patient recruitment and patient retention services market, over the next decade. The study also features an in-depth analysis, highlighting the capabilities of various industry stakeholders engaged in this field.
Clinical trials form an integral part of the overall drug development process, enabling the necessary evaluation of the safety and efficacy of a drug candidate. As these trials are prone to delays, and can even fail altogether, they impose an immense financial pressure on sponsors. Studies suggest that around 40% of the total investment made for the development of a drug candidate is dedicated to clinical trials.
However, the conduct of such trials is often fraught with challenges, including scientific and operational complexity, concerns associated with recruitment and retention of suitable patients, issues related to data handling and increasingly stringent regulatory guidelines.
Further, owing to the inherent complexity of the overall process and involvement of several different stakeholders, these trials are prone to delays. It is worth mentioning that around 80% of the clinical trials are delayed due to insufficient patient recruitment. Further, retaining patients is also a major concern in pharmaceutical research and development; 15% to 40% of the enrolled patients drop out before the studies are completed, significantly impacting product approvals / launch timelines.
Therefore, patient outreach, patient recruitment and patient retention strategies have evolved significantly, especially with the availability of a variety of digital data generation, management and marketing solutions. In fact, a number of modern technology-enabled offerings are now available to support various aspects of clinical research and patient recruitment.
Q1. What is the current market landscape of the patient recruitment and patient retention services market?
Amongst several known challenges, patient recruitment is considered to be one of the rate limiting steps when it comes to getting drugs to the market. Presently, more than 155 companies have the required capabilities to offer patient recruitment services and patient retention services across different geographical locations.
Such service providers employ a variety of outreach methods and, over time, have attained a vital role in the successful conduct of clinical research. Further, several contract service providers are entering into strategic alliances in order to enhance their respective capabilities and offer an expanded portfolio of services to their clients.
Q2. How has outsourcing evolved in the patient recruitment and patient retention domain?
Several small and mid-sized players do not have dedicated patient enrolment teams and lack the necessary capabilities / expertise to successfully recruit desired number of patients in clinical trials. In some cases, the clinical studies are too large or geographically broad to be managed by internal staff. Further, the stringent ethical and regulatory guidelines associated with patient enrollment in trials impose a significant burden on drug developers.
As a result, outsourcing has become a popular operating model with regards to patient recruitment and patient retention; several specialty service providers, with expertise and experience in this domain, are driving the growth of this upcoming segment of the healthcare market. The advantages of engaging contract service providers are numerous and enable sponsors to meet their clinical research timelines and thereby, launch respective offerings as planned.
Q3. What are the recent developments and expected trends in the patient recruitment and patient retention domain?
Over the past decade, the patient recruitment and patient retention industry has witnessed tremendous increase in the use of social media platforms, including Facebook, Instagram, Pinterest, LinkedIn and Twitter, and mobile applications for engaging and recruiting patients in clinical studies; these approaches are cost-effective and can be used to connect with diverse and hard-to-reach patient populations.
In pursuit of capability and competence improvements, several service providers have also begun adopting and implementing modern technical strategies, such as Electronic Health Records (EHRs) and Real-World Evidence (RWE) for patient enrolment; these novel methods tend to be more efficient and yield a narrow pool of potentially eligible participants for targeted mailings.
Q4. What are the key challenges faced by patient recruitment and patient retention service providers?
The primary challenge faced by patient recruitment and patient retention service providers is the lack of awareness amongst individuals regarding the clinical studies and the benefits offered to study participants. Further, pharmaceutical companies do not allocate adequate budget for carrying out the patient enrolment process.
Specifically for clinical trials evaluating orphan drugs and personalized therapies, finding the specialized pool of eligible patients is a burdensome and costly task. Other challenges in this domain include fear of individuals about the adverse events associated with clinical trials, lack of communication between study participants and researchers due to language barrier, and large geographical distance between the patient's residence and study site, which affect the participation and patient retention in research studies.
Q5. What are the key value drivers in the patient recruitment and patient retention service market?
Owing to rise in the number of clinical trials that seek to enroll millions of patients, and complexities associated with patient accrual, drug developers are likely to outsource the patient recruitment and patient retention process to service providers. Moreover, we believe that increase in clinical development activity in emerging markets, availability of one-stop patient recruitment service providers, and stringent regulations related to patient enrollment are likely to provide further impetus to the patient recruitment services market.
Q6. What is the current market scenario and likely growth associated with patient recruitment services domain?
The patient recruitment services market is anticipated to grow at a steady pace in the coming years. Owing to the need for large and diverse patient populations, phase III trials are anticipated to be responsible for the maximum share of revenues within this domain.
Currently, in terms of therapeutic area, the market is captured by patient recruitment projects for trials evaluating drugs intended for the treatment of cardiovascular disorders. However, this trend is likely to change in the foreseen future with the rising clinical trials focusing on therapeutics targeting oncological disorders. Specifically, in terms of geography, the patient recruitment services market in Asia Pacific is likely to grow at a relatively faster pace in the long term.
Key Topics Covered:
2. EXECUTIVE SUMMARY
4. PATIENT OUTREACH METHODS
4.1. Chapter Overview
4.2. Patient Outreach Methods
5. MARKET LANDSCAPE
5.1. Chapter Overview
5.2. Patient Recruitment and Retention Service Providers: Overall Market Landscape
6. COMPANY COMPETITIVENESS ANALYSIS
6.1. Chapter Overview
6.2. Assumptions and Key Parameters
6.4. Patient Recruitment and Retention Service Providers: Company Competitiveness Analysis
7. COMPANY PROFILES: PATIENT RECRUITMENT AND RETENTION SERVICES PROVIDERS IN NORTH AMERICA
7.1. Chapter Overview
7.2. BBK Worldwide (A Publicis Health Company)
7.2.1. Company Overview
7.2.2. Patient Recruitment and Retention Services Portfolio
7.2.3. Recent Developments and Future Outlook
7.3. Continuum Clinical
7.5. United BioSource (UBC)
7.6. WCG ThreeWire
8. COMPANY PROFILES: PATIENT RECRUITMENT AND RETENTION SERVICES PROVIDERS IN EUROPE
8.1. Chapter Overview
8.3. Ignite Data
8.4. Innovative Trials
8.5. One Research
8.6. Orphan Reach
9. COMPANY PROFILES: PATIENT RECRUITMENT AND RETENTION SERVICES PROVIDERS IN ASIA-PACIFIC AND REST OF THE WORLD
9.1. Chapter Overview
9.2. 3H Medi Solution
9.4. Current Medical Information Center (CMIC)
9.6.1. Company Overview
10. PARTNERSHIPS AND COLLABORATIONS
10.1. Chapter Overview
10.2. Partnership Models
10.3. Patient Recruitment and Retention Services: List of Partnerships and Collaborations
11. RECENT TRENDS IN PATIENT RECRUITMENT AND RETENTION
11.1. Chapter Overview
11.1.1. Campaigning on Social Media to Accelerate Patient Recruitment in Clinical Trials
11.1.2. Adoption of Mobile Technologies for Patient Recruitment and Retention
11.1.3. Use of EHR Data to Improve Patient Recruitment Rates
11.1.4. Use of Other Real-World Data Sources to Overcome Patient Enrolment-related Challenges
11.1.5. Use of Artificial Intelligence to Improve Patient Selection
11.1.6. Increase in Adoption of the Virtual Trial Model During the COVID-19 Pandemic
11.1.7. Growing Focus on Conducting Clinical Research in Emerging Markets
12. FUTURE GROWTH OPPORTUNITIES IN PATIENT RECRUITMENT
12.1. Chapter Overview
12.2. Continuous Rise in the Number of Global Clinical Trials
12.3. Rise in Demand for Orphan Drugs and Personalized Medicine
12.4. Increase in Offshoring Clinical Development Activity to Emerging Regions
12.5. Availability of Service Providers Offering One-Stop-Solutions
12.6. Stringent Regulations and Complex Study Protocols Prompting More Outsourcing
12.7. Impact of the COVID-19 Pandemic on Clinical Research Activity
12.8. Technological Advances in Clinical Trial Conduct
13. CASE STUDY: REGULATORY LANDSCAPE OF PATIENT RECRUITMENT
13.1. Chapter Overview
13.2. Regulatory Framework of Patient Recruitment
13.3. Regulations Involved in Patient Recruitment
14. PATIENT RECRUITMENT IN TRIALS FOCUSED ON PERSONALIZED MEDICINES AND RARE DISEASES
14.1. Chapter Overview
14.2. Clinical Trials Focused on Personalized Medicines and Rare Diseases
15. ANALYSIS OF DEMAND FOR CLINICAL TRIAL PARTICIPANTS
15.1. Chapter Overview
15.2. Scope and Methodology
15.3. Clinical Trial Analysis
15.4. Global Demand for Clinical Trial Participants
16. MARKET SIZING AND OPPORTUNITY ANALYSIS
16.1. Chapter Overview
16.2. Forecast Methodology and Key Assumptions
16.3. Global Patient Recruitment Services Market, 2022-2035
16.4. Patient Recruitment Services Market: Analysis by Patient Recruitment Steps, 2022-2035
16.5. Patient Recruitment Services Market: Analysis by Trial Phase, 2022-2035
16.6. Patient Recruitment Services Market: Analysis by Therapeutic Area, 2022-2035
16.7. Patient Recruitment Services Market: Analysis by Geography, 2022-2035
17. IMPACT OF THE COVID-19 PANDEMIC ON PATIENT RECRUITMENT SERVICES MARKET
18. CONCLUDING REMARKS
19. EXECUTIVE INSIGHTS
20. APPENDIX 1: TABULATED DATA
21. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
For more information about this report visit https://www.researchandmarkets.com/r/dg2ucn
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
View original content:https://www.prnewswire.com/news-releases/global-patient-recruitment-services-and-patient-retention-services-market-report-to-2035-players-featured-include-bbk-worldwide-continuum-clinical-iqvia-united-biosource-and-wcg-threewire-301707016.html
SOURCE Research and Markets
||Tredence Named a Leader in Analytics Services by ISG | Feb 6, 2023
||Global Precision Guided Ammunitions Market Report 2023-2031 with Country Analysis of USA, Germany, Netherlands, Poland, Japan, Italy, and France | Feb 6, 2023
||Practice Management Systems Market Will Reach $25,320.7 Million by 2030, Says P&S Intelligence | Feb 6, 2023
||Digital transformation services market size to increase by USD 737.27 billion: North America will account for 35% of the market's growth during the forecast period - Technavio | Feb 6, 2023
||New novel takes readers on an action-packed adventure as one woman faces new battles, new people and a whole lot of new powers | Feb 6, 2023
||Digital Health Global Market Report 2023: Featuring Ampersand Health, Livongo Health, CogniFit, JOGO Health & More | Feb 6, 2023
||CRN Recognizes Flexential® as a Cloud 100 Company for 2023 | Feb 6, 2023
||Data Exfiltration Techniques Market to Reach $217.5 Billion, Globally, by 2031 at 12.3% CAGR: Allied Market Research | Feb 6, 2023
||Long-Acting Drug Delivery Technologies and Services Global Market Report 2023: Industry to Grow by 13% Annually Through 2035 | Feb 6, 2023
||Porous Silicon Substrates Market Expected to Reach $10.5 Billion Globally, By 2031 at 7.6% CAGR: Allied Market Research | Feb 6, 2023